Similar companies
Income Statement (USD)
Q2 '24 | QoQ | |
---|---|---|
Revenue | 757M | 7.5% |
Gross Profit | 473M | 11.1% |
Cost of Revenue | 284M | 1.9% |
Operating expense | 677M | 5.6% |
Net Income | -16M | 25% |
EBITDA | 97M | 475% |
Balance Sheet (USD)
Q2 '24 | QoQ | |
---|---|---|
Total Assets | 7.49B | 7.4% |
Total Liabilities | 5.54B | 10.5% |
Total Equity | 1.95B | 0.8% |
Shares Outstanding | 127M | 0% |
Cash Flow (USD)
Q2 '24 | QoQ | |
---|---|---|
Cash from operations | 83M | 103.4% |
Cash from investing | -244M | 193.7% |
Cash from financing | 190M | 498.1% |
EPS
Financial Highlights for Surgery Partners in Q2 '24
Surgery Partners reported a revenue of 757M, which is a 7.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 473M, marking a 11.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 284M, a 1.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 677M, showing a 5.6% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -16M, showing a -25% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 97M, showing a 475% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Surgery Partners faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies.